Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 192 entries
Sorted by: Best Match Show Resources per page
Relativistic impulse approximation in an additive potential model.

Physical review. C, Nuclear physics

Harrington DR.
PMID: 9954069
Phys Rev C Nucl Phys. 1987 Jul;36(1):264-271. doi: 10.1103/physrevc.36.264.

No abstract available.

Cite
Harrington DR. Relativistic impulse approximation in an additive potential model. Phys Rev C Nucl Phys. 1987;36(1):264-271doi: 10.1103/physrevc.36.264.
Harrington, D. R. (1987). Relativistic impulse approximation in an additive potential model. Physical review. C, Nuclear physics, 36(1), 264-271. https://doi.org/10.1103/physrevc.36.264
Harrington. "Relativistic impulse approximation in an additive potential model." Physical review. C, Nuclear physics vol. 36,1 (1987): 264-271. doi: https://doi.org/10.1103/physrevc.36.264
Harrington DR. Relativistic impulse approximation in an additive potential model. Phys Rev C Nucl Phys. 1987 Jul;36(1):264-271. doi: 10.1103/physrevc.36.264. PMID: 9954069.
Copy Download .nbib Format: NLM
Clinically apparent adverse reactions to intra-wound vancomycin powder in early onset scoliosis are rare.

Journal of children's orthopaedics

DeFrancesco CJ, Flynn JM, Smith JT, Luhmann SJ, Sawyer JR, Glotzbecker M, Pahys J, Garg S, Vitale M, Farrington DM, Sturm P.
PMID: 29263752
J Child Orthop. 2017 Dec 01;11(6):414-418. doi: 10.1302/1863-2548.11.170107.

PURPOSE: Spine surgeons have increasingly used intraoperative application of topical vancomycin powder (TVP) to prevent surgical site infections (SSIs). The goals of this study were to define the rate of pharmacological adverse reaction to TVP in young patients undergoing...

Cite
DeFrancesco CJ, Flynn JM, Smith JT, et al. Clinically apparent adverse reactions to intra-wound vancomycin powder in early onset scoliosis are rare. J Child Orthop. 2017;11(6):414-418doi: 10.1302/1863-2548.11.170107.
DeFrancesco, C. J., Flynn, J. M., Smith, J. T., Luhmann, S. J., Sawyer, J. R., Glotzbecker, M., Pahys, J., Garg, S., Vitale, M., Farrington, D. M., Sturm, P. (2017). Clinically apparent adverse reactions to intra-wound vancomycin powder in early onset scoliosis are rare. Journal of children's orthopaedics, 11(6), 414-418. https://doi.org/10.1302/1863-2548.11.170107
DeFrancesco, C J, et al. "Clinically apparent adverse reactions to intra-wound vancomycin powder in early onset scoliosis are rare." Journal of children's orthopaedics vol. 11,6 (2017): 414-418. doi: https://doi.org/10.1302/1863-2548.11.170107
DeFrancesco CJ, Flynn JM, Smith JT, Luhmann SJ, Sawyer JR, Glotzbecker M, Pahys J, Garg S, Vitale M, Farrington DM, Sturm P. Clinically apparent adverse reactions to intra-wound vancomycin powder in early onset scoliosis are rare. J Child Orthop. 2017 Dec 01;11(6):414-418. doi: 10.1302/1863-2548.11.170107. PMID: 29263752; PMCID: PMC5725766.
Copy Download .nbib Format: NLM
Dietary quality in children and the role of the local food environment.

SSM - population health

Keane E, Cullinan J, Perry CP, Kearney PM, Harrington JM, Perry IJ, Layte R.
PMID: 29349188
SSM Popul Health. 2016 Oct 11;2:770-777. doi: 10.1016/j.ssmph.2016.10.002. eCollection 2016 Dec.

Diet is a modifiable contributor to many chronic diseases including childhood obesity. The local food environment may influence children's diet but this area of research is understudied. This study explores if distance to and the number of supermarkets and...

Cite
Keane E, Cullinan J, Perry CP, et al. Dietary quality in children and the role of the local food environment. SSM Popul Health. 2016;2:770-777doi: 10.1016/j.ssmph.2016.10.002.
Keane, E., Cullinan, J., Perry, C. P., Kearney, P. M., Harrington, J. M., Perry, I. J., & Layte, R. (2016). Dietary quality in children and the role of the local food environment. SSM - population health, 2770-777. https://doi.org/10.1016/j.ssmph.2016.10.002
Keane, Eimear, et al. "Dietary quality in children and the role of the local food environment." SSM - population health vol. 2 (2016): 770-777. doi: https://doi.org/10.1016/j.ssmph.2016.10.002
Keane E, Cullinan J, Perry CP, Kearney PM, Harrington JM, Perry IJ, Layte R. Dietary quality in children and the role of the local food environment. SSM Popul Health. 2016 Oct 11;2:770-777. doi: 10.1016/j.ssmph.2016.10.002. eCollection 2016 Dec. PMID: 29349188; PMCID: PMC5757931.
Copy Download .nbib Format: NLM
Evaluating the extent of a large-scale transformation in gateway science courses.

Science advances

Matz RL, Fata-Hartley CL, Posey LA, Laverty JT, Underwood SM, Carmel JH, Herrington DG, Stowe RL, Caballero MD, Ebert-May D, Cooper MM.
PMID: 30397646
Sci Adv. 2018 Oct 24;4(10):eaau0554. doi: 10.1126/sciadv.aau0554. eCollection 2018 Oct.

We evaluate the impact of an institutional effort to transform undergraduate science courses using an approach based on course assessments. The approach is guided by

Cite
Matz RL, Fata-Hartley CL, Posey LA, et al. Evaluating the extent of a large-scale transformation in gateway science courses. Sci Adv. 2018;4(10):eaau0554doi: 10.1126/sciadv.aau0554.
Matz, R. L., Fata-Hartley, C. L., Posey, L. A., Laverty, J. T., Underwood, S. M., Carmel, J. H., Herrington, D. G., Stowe, R. L., Caballero, M. D., Ebert-May, D., & Cooper, M. M. (2018). Evaluating the extent of a large-scale transformation in gateway science courses. Science advances, 4(10), eaau0554. https://doi.org/10.1126/sciadv.aau0554
Matz, Rebecca L, et al. "Evaluating the extent of a large-scale transformation in gateway science courses." Science advances vol. 4,10 (2018): eaau0554. doi: https://doi.org/10.1126/sciadv.aau0554
Matz RL, Fata-Hartley CL, Posey LA, Laverty JT, Underwood SM, Carmel JH, Herrington DG, Stowe RL, Caballero MD, Ebert-May D, Cooper MM. Evaluating the extent of a large-scale transformation in gateway science courses. Sci Adv. 2018 Oct 24;4(10):eaau0554. doi: 10.1126/sciadv.aau0554. eCollection 2018 Oct. PMID: 30397646; PMCID: PMC6200365.
Copy Download .nbib Format: NLM
Design and conduct of a provider survey to determine a clinically persuasive effect size in planning VA Cooperative Study #590 (Li+).

Contemporary clinical trials communications

Harrington KM, Liang MH, Hannagan K, Thwin SS, Ferguson RE, Morgenstern N, Flores E, Katz IR.
PMID: 29736478
Contemp Clin Trials Commun. 2016 Aug 31;4:149-154. doi: 10.1016/j.conctc.2016.08.004. eCollection 2016 Dec 15.

BACKGROUND: The estimation of an effect size is an important step in designing an adequately powered, feasible clinical trial intended to change clinical practice. During the planning phase of VA Cooperative Study #590, "Double-Blind Placebo-Controlled Study of Lithium for...

Cite
Harrington KM, Liang MH, Hannagan K, et al. Design and conduct of a provider survey to determine a clinically persuasive effect size in planning VA Cooperative Study #590 (Li+). Contemp Clin Trials Commun. 2016;4:149-154doi: 10.1016/j.conctc.2016.08.004.
Harrington, K. M., Liang, M. H., Hannagan, K., Thwin, S. S., Ferguson, R. E., Morgenstern, N., Flores, E., & Katz, I. R. (2016). Design and conduct of a provider survey to determine a clinically persuasive effect size in planning VA Cooperative Study #590 (Li+). Contemporary clinical trials communications, 4149-154. https://doi.org/10.1016/j.conctc.2016.08.004
Harrington, Kelly M, et al. "Design and conduct of a provider survey to determine a clinically persuasive effect size in planning VA Cooperative Study #590 (Li+)." Contemporary clinical trials communications vol. 4 (2016): 149-154. doi: https://doi.org/10.1016/j.conctc.2016.08.004
Harrington KM, Liang MH, Hannagan K, Thwin SS, Ferguson RE, Morgenstern N, Flores E, Katz IR. Design and conduct of a provider survey to determine a clinically persuasive effect size in planning VA Cooperative Study #590 (Li+). Contemp Clin Trials Commun. 2016 Aug 31;4:149-154. doi: 10.1016/j.conctc.2016.08.004. eCollection 2016 Dec 15. PMID: 29736478; PMCID: PMC5935897.
Copy Download .nbib Format: NLM
Improving Emotional Intelligence through Personality Development: The Effect of the Smart Phone Application based Dharma Life Program on Emotional Intelligence.

Frontiers in psychology

Poonamallee L, Harrington AM, Nagpal M, Musial A.
PMID: 29527182
Front Psychol. 2018 Feb 23;9:169. doi: 10.3389/fpsyg.2018.00169. eCollection 2018.

Emotional intelligence is established to predict success in leadership effectiveness in various contexts and has been linked to personality factors. This paper introduces Dharma Life Program, a novel approach to improving emotional intelligence by targeting maladaptive personality traits and...

Cite
Poonamallee L, Harrington AM, Nagpal M, et al. Improving Emotional Intelligence through Personality Development: The Effect of the Smart Phone Application based Dharma Life Program on Emotional Intelligence. Front Psychol. 2018;9:169doi: 10.3389/fpsyg.2018.00169.
Poonamallee, L., Harrington, A. M., Nagpal, M., & Musial, A. (2018). Improving Emotional Intelligence through Personality Development: The Effect of the Smart Phone Application based Dharma Life Program on Emotional Intelligence. Frontiers in psychology, 9169. https://doi.org/10.3389/fpsyg.2018.00169
Poonamallee, Latha, et al. "Improving Emotional Intelligence through Personality Development: The Effect of the Smart Phone Application based Dharma Life Program on Emotional Intelligence." Frontiers in psychology vol. 9 (2018): 169. doi: https://doi.org/10.3389/fpsyg.2018.00169
Poonamallee L, Harrington AM, Nagpal M, Musial A. Improving Emotional Intelligence through Personality Development: The Effect of the Smart Phone Application based Dharma Life Program on Emotional Intelligence. Front Psychol. 2018 Feb 23;9:169. doi: 10.3389/fpsyg.2018.00169. eCollection 2018. PMID: 29527182; PMCID: PMC5829461.
Copy Download .nbib Format: NLM
Altered Functional Interactions of Inhibition Regions in Cognitively Normal Parkinson's Disease.

Frontiers in aging neuroscience

Harrington DL, Shen Q, Theilmann RJ, Castillo GN, Litvan I, Filoteo JV, Huang M, Lee RR.
PMID: 30405399
Front Aging Neurosci. 2018 Oct 23;10:331. doi: 10.3389/fnagi.2018.00331. eCollection 2018.

Deficient inhibitory control in Parkinson's disease (PD) is often observed in situations requiring inhibition of impulsive or prepotent behaviors. Although activation of the right-hemisphere frontal-basal ganglia response inhibition network is partly altered in PD, disturbances in interactions of these...

Cite
Harrington DL, Shen Q, Theilmann RJ, et al. Altered Functional Interactions of Inhibition Regions in Cognitively Normal Parkinson's Disease. Front Aging Neurosci. 2018;10:331doi: 10.3389/fnagi.2018.00331.
Harrington, D. L., Shen, Q., Theilmann, R. J., Castillo, G. N., Litvan, I., Filoteo, J. V., Huang, M., & Lee, R. R. (2018). Altered Functional Interactions of Inhibition Regions in Cognitively Normal Parkinson's Disease. Frontiers in aging neuroscience, 10331. https://doi.org/10.3389/fnagi.2018.00331
Harrington, Deborah L, et al. "Altered Functional Interactions of Inhibition Regions in Cognitively Normal Parkinson's Disease." Frontiers in aging neuroscience vol. 10 (2018): 331. doi: https://doi.org/10.3389/fnagi.2018.00331
Harrington DL, Shen Q, Theilmann RJ, Castillo GN, Litvan I, Filoteo JV, Huang M, Lee RR. Altered Functional Interactions of Inhibition Regions in Cognitively Normal Parkinson's Disease. Front Aging Neurosci. 2018 Oct 23;10:331. doi: 10.3389/fnagi.2018.00331. eCollection 2018. PMID: 30405399; PMCID: PMC6206214.
Copy Download .nbib Format: NLM
Arabidopsis AtCNGC10 rescues potassium channel mutants of E. coli, yeast and Arabidopsis and is regulated by calcium/calmodulin and cyclic GMP in E. coli.

Functional plant biology : FPB

Li X, Borsics T, Harrington HM, Christopher DA.
PMID: 32689163
Funct Plant Biol. 2005 Aug;32(7):643-653. doi: 10.1071/FP04233.

We have isolated and characterised AtCNGC10, one of the 20 members of the family of cyclic nucleotide (CN)-gated and calmodulin (CaM)-regulated channels (CNGCs) from Arabidopsis thaliana (L.) Heynh. AtCNGC10 bound CaM in a C-terminal subregion that contains a basic...

Cite
Li X, Borsics T, Harrington HM, et al. Arabidopsis AtCNGC10 rescues potassium channel mutants of E. coli, yeast and Arabidopsis and is regulated by calcium/calmodulin and cyclic GMP in E. coli. Funct Plant Biol. 2005;32(7):643-653doi: 10.1071/FP04233.
Li, X., Borsics, T., Harrington, H. M., & Christopher, D. A. (2005). Arabidopsis AtCNGC10 rescues potassium channel mutants of E. coli, yeast and Arabidopsis and is regulated by calcium/calmodulin and cyclic GMP in E. coli. Functional plant biology : FPB, 32(7), 643-653. https://doi.org/10.1071/FP04233
Li, Xinli, et al. "Arabidopsis AtCNGC10 rescues potassium channel mutants of E. coli, yeast and Arabidopsis and is regulated by calcium/calmodulin and cyclic GMP in E. coli." Functional plant biology : FPB vol. 32,7 (2005): 643-653. doi: https://doi.org/10.1071/FP04233
Li X, Borsics T, Harrington HM, Christopher DA. Arabidopsis AtCNGC10 rescues potassium channel mutants of E. coli, yeast and Arabidopsis and is regulated by calcium/calmodulin and cyclic GMP in E. coli. Funct Plant Biol. 2005 Aug;32(7):643-653. doi: 10.1071/FP04233. PMID: 32689163.
Copy Download .nbib Format: NLM
Genetic Risk Scores in Premature Coronary Artery Disease: Still Only One Piece of the Prevention Puzzle.

Circulation. Genomic and precision medicine

Assimes TL, Herrington DM.
PMID: 29874182
Circ Genom Precis Med. 2018 Jan;11(1):e002006. doi: 10.1161/CIRCGEN.117.002006.

No abstract available.

Cite
Assimes TL, Herrington DM. Genetic Risk Scores in Premature Coronary Artery Disease: Still Only One Piece of the Prevention Puzzle. Circ Genom Precis Med. 2018;11(1):e002006doi: 10.1161/CIRCGEN.117.002006.
Assimes, T. L., & Herrington, D. M. (2018). Genetic Risk Scores in Premature Coronary Artery Disease: Still Only One Piece of the Prevention Puzzle. Circulation. Genomic and precision medicine, 11(1), e002006. https://doi.org/10.1161/CIRCGEN.117.002006
Assimes, Themistocles L, and Herrington, David M. "Genetic Risk Scores in Premature Coronary Artery Disease: Still Only One Piece of the Prevention Puzzle." Circulation. Genomic and precision medicine vol. 11,1 (2018): e002006. doi: https://doi.org/10.1161/CIRCGEN.117.002006
Assimes TL, Herrington DM. Genetic Risk Scores in Premature Coronary Artery Disease: Still Only One Piece of the Prevention Puzzle. Circ Genom Precis Med. 2018 Jan;11(1):e002006. doi: 10.1161/CIRCGEN.117.002006. PMID: 29874182.
Copy Download .nbib Format: NLM
USING PROFILE LIKELIHOOD FOR SEMIPARAMETRIC MODEL SELECTION WITH APPLICATION TO PROPORTIONAL HAZARDS MIXED MODELS.

Statistica Sinica

Xu R, Vaida F, Harrington DP.
PMID: 31762585
Stat Sin. 2009 Apr;19(2):819-842.

We consider selection of nested and non-nested semiparametric models. Using profile likelihood we can define both a likelihood ratio statistic and an Akaike information for models with nuisance parameters. Asymptotic quadratic expansion of the log profile likelihood allows derivation...

Cite
Xu R, Vaida F, Harrington DP. USING PROFILE LIKELIHOOD FOR SEMIPARAMETRIC MODEL SELECTION WITH APPLICATION TO PROPORTIONAL HAZARDS MIXED MODELS. Stat Sin. 2009;19(2):819-842
Xu, R., Vaida, F., & Harrington, D. P. (2009). USING PROFILE LIKELIHOOD FOR SEMIPARAMETRIC MODEL SELECTION WITH APPLICATION TO PROPORTIONAL HAZARDS MIXED MODELS. Statistica Sinica, 19(2), 819-842.
Xu, Ronghui, et al. "USING PROFILE LIKELIHOOD FOR SEMIPARAMETRIC MODEL SELECTION WITH APPLICATION TO PROPORTIONAL HAZARDS MIXED MODELS." Statistica Sinica vol. 19,2 (2009): 819-842.
Xu R, Vaida F, Harrington DP. USING PROFILE LIKELIHOOD FOR SEMIPARAMETRIC MODEL SELECTION WITH APPLICATION TO PROPORTIONAL HAZARDS MIXED MODELS. Stat Sin. 2009 Apr;19(2):819-842. PMID: 31762585; PMCID: PMC6874104.
Copy Download .nbib Format: NLM
Week 96 extension results of a Phase 3 study evaluating long-acting cabotegravir with rilpivirine for HIV-1 treatment.

AIDS (London, England)

Swindells S, Lutz T, Van Zyl L, Porteiro N, Stoll M, Mitha E, Shon A, Benn P, Huang JO, Harrington CM, Hove K, Ford SL, Talarico CL, Chounta V, Crauwels H, Van Solingen-Ristea R, Vanveggel S, Margolis DA, Smith KY, Vandermeulen K, Spreen WR.
PMID: 34261093
AIDS. 2022 Feb 01;36(2):185-194. doi: 10.1097/QAD.0000000000003025.

BACKGROUND: ATLAS (NCT02951052), a phase 3, multicenter, open-label study, demonstrated that switching to injectable cabotegravir (CAB) with rilpivirine (RPV) long-acting dosed every 4 weeks was noninferior at week (W) 48 to continuing three-drug daily oral current antiretroviral therapy (CAR)....

Cite
Swindells S, Lutz T, Van Zyl L, et al. Week 96 extension results of a Phase 3 study evaluating long-acting cabotegravir with rilpivirine for HIV-1 treatment. AIDS. 2022;36(2):185-194doi: 10.1097/QAD.0000000000003025.
Swindells, S., Lutz, T., Van Zyl, L., Porteiro, N., Stoll, M., Mitha, E., Shon, A., Benn, P., Huang, J. O., Harrington, C. M., Hove, K., Ford, S. L., Talarico, C. L., Chounta, V., Crauwels, H., Van Solingen-Ristea, R., Vanveggel, S., Margolis, D. A., Smith, K. Y., Vandermeulen, K., & Spreen, W. R. (2022). Week 96 extension results of a Phase 3 study evaluating long-acting cabotegravir with rilpivirine for HIV-1 treatment. AIDS (London, England), 36(2), 185-194. https://doi.org/10.1097/QAD.0000000000003025
Swindells, Susan, et al. "Week 96 extension results of a Phase 3 study evaluating long-acting cabotegravir with rilpivirine for HIV-1 treatment." AIDS (London, England) vol. 36,2 (2022): 185-194. doi: https://doi.org/10.1097/QAD.0000000000003025
Swindells S, Lutz T, Van Zyl L, Porteiro N, Stoll M, Mitha E, Shon A, Benn P, Huang JO, Harrington CM, Hove K, Ford SL, Talarico CL, Chounta V, Crauwels H, Van Solingen-Ristea R, Vanveggel S, Margolis DA, Smith KY, Vandermeulen K, Spreen WR. Week 96 extension results of a Phase 3 study evaluating long-acting cabotegravir with rilpivirine for HIV-1 treatment. AIDS. 2022 Feb 01;36(2):185-194. doi: 10.1097/QAD.0000000000003025. PMID: 34261093; PMCID: PMC8711605.
Copy Download .nbib Format: NLM
Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain.

Trends in pharmacological sciences

Brierley SM, Grundy L, Castro J, Harrington AM, Hannig G, Camilleri M.
PMID: 34865885
Trends Pharmacol Sci. 2021 Dec 02; doi: 10.1016/j.tips.2021.11.002. Epub 2021 Dec 02.

Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by abdominal pain and altered bowel habit that affects ~11% of the global population. Over the past decade, preclinical and clinical studies have revealed a variety of novel mechanisms...

Cite
Brierley SM, Grundy L, Castro J, et al. Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain. Trends Pharmacol Sci. 2021;doi: 10.1016/j.tips.2021.11.002.
Brierley, S. M., Grundy, L., Castro, J., Harrington, A. M., Hannig, G., & Camilleri, M. (2021). Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain. Trends in pharmacological sciences, . https://doi.org/10.1016/j.tips.2021.11.002
Brierley, Stuart M, et al. "Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain." Trends in pharmacological sciences vol. (2021). doi: https://doi.org/10.1016/j.tips.2021.11.002
Brierley SM, Grundy L, Castro J, Harrington AM, Hannig G, Camilleri M. Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain. Trends Pharmacol Sci. 2021 Dec 02; doi: 10.1016/j.tips.2021.11.002. Epub 2021 Dec 02. PMID: 34865885.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 192 entries